GlassScriptPhysician profile
Brittney Heath Preslar
NPI 1912520958
$440.46
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $397 · 2022: $43.88.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $81.29 | 2021 | |
| Sunovion Pharmaceuticals INC. | $70.65 | 2021 | |
| Abbvie INC. | $45.65 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $41.18 | 2021 | |
| Amgen INC. | $32.22 | 2021-2022 | |
| Novo Nordisk INC | $27.88 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $27.79 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $18.89 | 2021 | |
| Merck Sharp & Dohme LLC | $17.39 | 2021 | |
| Amarin Pharma, INC. | $16.98 | 2021 | |
| Mylan Specialty L.P. | $15.29 | 2021 | |
| Glaxosmithkline, LLC. | $14.57 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.55 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.30 | 2022 | |
| Genentech USA, INC. | $1.83 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittney Preslar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.